Stock Market Update: Both Sensex and Nifty indices have weakened

Stock Market Update Today: Selling is also being seen in the domestic stock market amid weak global cues. Both Sensex and Nifty indices have weakened in today’s trading.

There is a fall of about 400 points in the Sensex, then the Nifty has also come close to 15650. All-round selling is being seen in today’s business.

Bank and financial indices on Nifty have more than 1 percent weakness. The auto index has also fallen by more than 1 percent.

The FMCG index has a weakness of about 1 percent. Other indices including IT, Metal, Pharma and Realty are also in the red mark.

At present, there is a weakness of 395 points in the Sensex and it is trading at the level of 52624. Whereas Nifty is at the level of 15661 after breaking 119 points.

Selling is being seen in heavyweight stocks. 24 stocks of Sensex 30 are seen in red mark. Today’s top losers include TITAN, DRREDDY, M&M, KOTAKBANK, MARUTI, BAJFINANCE and HDFC.

Bharti Airtel has said that the company has opted to defer the payment of AGR dues (which have not been calculated in the Supreme Court order) till the financial year 2018-19. The company said that the company has retained the right to pre-pay installment amount and will not opt ​​to convert the outstanding interest into equity.

Agrochemical firm UPL has acquired 100 per cent stake in Nature Bliss Agro (NBAL) and NBAL has now become a wholly owned subsidiary of UPL. NBAL proposes to undertake the business of manufacturing and selling of crop protection and allied products, which is in sync with the existing business activities of UPL.

Pharma company Lupine has received approval from the US FDA for its Abbreviated New Drug Application (ANDA)-Paliperidone Extended-Release Tablets. The product will be manufactured at Lupine’s facility in Goa. This medication is used in schizophrenia, which is a mental disorder.

Also Read – PM Modi directs recruitment of 10 lakh people over next 1.5 years

Keep watching our YouTube Channel ‘DNP INDIA’. Also, please subscribe and follow us on FACEBOOKINSTAGRAM, and TWITTER.

Exit mobile version